More Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. Endocr Pract 2022 Mar;28(3):353-354
Date
01/26/2022Pubmed ID
35074501DOI
10.1016/j.eprac.2022.01.004Scopus ID
2-s2.0-85125482531 (requires institutional sign-in at Scopus site)Author List
Sarvaideo J, Doll E, Tangpricha VAuthor
Jenna Sarvaideo DO Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
EstradiolFemale
Humans
Transgender Persons
Transsexualism
